Two Sigma Securities’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-47,100
Closed -$361K 2354
2019
Q2
$361K Buy
+47,100
New +$254K ﹤0.01% 1347
2018
Q4
Sell
-14,300
Closed -$246K 2671
2018
Q3
$246K Sell
14,300
-26,500
-65% -$394K ﹤0.01% 1922
2018
Q2
$569K Buy
40,800
+17,200
+73% +$290K ﹤0.01% 1673
2018
Q1
$362K Buy
+23,600
New +$337K ﹤0.01% 1875

Other funds holding PGEN

Two Sigma Securities's PGEN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Precigen (PGEN) in Q1 2026: 15,132 shares worth $58.6K. The stake represents 0.01% of the portfolio and ranks #1250 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PGEN as recently as Q3 2025.

Two Sigma Securities first reported a position in PGEN in Q2 2017 and has held it in 14 quarters since. The position peaked at $374K in Q3 2025. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Two Sigma Securities held 15,132 shares of Precigen worth $58.6K as of Q1 2026.
  • Precigen was a new Two Sigma Securities position in Q1 2026.
  • Precigen made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1250 holding.
  • Two Sigma Securities first reported a position in Precigen in Q2 2017 and has held it in 14 quarters since.
  • Two Sigma Securities's Precigen position peaked at $374K in Q3 2025.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.